Sign In
Buy MS
$214.04
+1.38 (+0.649%)
At Close: Jun 12, 2026
Morgan Stanley Investment Management's 1GT Invests in Series C Funding for Overhaul Group
09:02am, Wednesday, 20'th Aug 2025
NEW YORK--(BUSINESS WIRE)--Morgan Stanley Investment Management (MSIM) announced today that the 1GT climate private equity strategy (1GT) participated in the $105 million Series C equity financing of
Winklevoss twins-led crypto firm Gemini files for US IPO
12:40pm, Monday, 18'th Aug 2025
Gemini Space Station, the cryptocurrency company founded by twins Cameron and Tyler Winklevoss, has filed for an initial public offering in the United States. The company plans to list its shares on t
Our Top 10 High Growth Dividend Stocks - August 2025
08:15am, Saturday, 16'th Aug 2025
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rat
Morgan Stanley Declares Dividends on Its Preferred Stock
04:30pm, Friday, 15'th Aug 2025
NEW YORK--(BUSINESS WIRE)--Morgan Stanley today declared a regular dividend on the outstanding shares of each of the following preferred stock issues: Floating Rate Non-Cumulative Preferred Stock, Ser
Morgan Stanley (MS) Up 5.4% Since Last Earnings Report: Can It Continue?
12:31pm, Friday, 15'th Aug 2025
Morgan Stanley (MS) reported earnings 30 days ago. What's next for the stock?
Dan Simkowitz to Speak at the Barclays Global Financial Services Conference
04:30pm, Wednesday, 13'th Aug 2025
NEW YORK--(BUSINESS WIRE)--Dan Simkowitz, Co-President of Morgan Stanley, will speak at the Barclays Global Financial Services Conference on September 10, 2025, at 9:00 a.m. (ET). Both live and on-dem
Morgan Stanley Stock Touches All-Time High: Should You Invest?
12:31pm, Wednesday, 13'th Aug 2025
MS hits a record $148.23 amid a market rally fueled by rate cut hopes, but rising costs and trading reliance pose challenges.
Investors Heavily Search Morgan Stanley (MS): Here is What You Need to Know
10:01am, Tuesday, 12'th Aug 2025
Zacks.com users have recently been watching Morgan Stanley (MS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
JPM or MS: Which Investment Banking Powerhouse is the Better Buy Now?
09:56am, Tuesday, 12'th Aug 2025
Can JPMorgan's IB dominance, trading strength and diversified revenues give it an edge over Morgan Stanley in a volatile market? Let's take a closer look.
Ørsted to raise $9.4bn with rights issue
07:44am, Monday, 11'th Aug 2025
Danish renewable energy firm Ørsted announced a fully underwritten rights issue to raise the equivalent of $9.4 billion (60 billion Danish Kroner, DKK). The Danish state, which owns 50.1% of Ørsted,
Morgan Stanley Q2 EPS Falls 38%
12:43am, Friday, 08'th Aug 2025
Morgan Stanley Q2 EPS Falls 38%
Afya upgraded to Equal Weight from Underweight at Morgan Stanley
08:23pm, Tuesday, 05'th Aug 2025
Morgan Stanley upgraded Afya to Equal Weight from Underweight with a price target of $17.50, down from $19, as part of a broader research note on Brazil Education Services. The new sector regulation w
Y-mAbs Therapeutics upgraded to Equal Weight from Underweight at Morgan Stanley
04:49pm, Tuesday, 05'th Aug 2025
Morgan Stanley upgraded Y-mAbs Therapeutics to Equal Weight from Underweight with a price target of $8.60, up from $7, after the company agreed to be acquired by SERB Pharmaceuticals for $8.60 per sha
Semrush downgraded to Equal Weight from Overweight at Morgan Stanley
04:21pm, Tuesday, 05'th Aug 2025
Morgan Stanley analyst Elizabeth Porter downgraded Semrush to Equal Weight from Overweight with a price target of $9, down from $13. Momentum in enterprise and early AI solutions are not enough to off
Idexx Laboratories price target raised to $722 from $626 at Morgan Stanley
03:44pm, Tuesday, 05'th Aug 2025
Morgan Stanley raised the firm's price target on Idexx Laboratories to $722 from $626 and keeps an Overweight rating on the shares. Following the Q2 results, what "stood out to us" was accelerating co
